YIDU TECH (02158) announced through a voluntary announcement on May 11 that its affiliated company, Yidu Cloud (Beijing) Technology Co., Ltd., recently won the bid for the Smart Clinical and Settlement Service Upgrade Construction Project of Sun Yat-sen University Cancer Center (referred to as "ZSCC"). The winning bid amount is approximately RMB 9.082 million. This marks another key order for intelligent upgrade from a top-tier specialized hospital, following the company's consecutive wins of projects including Beijing Cancer Hospital's AI large model, the Hainan Provincial Public Health Platform, and Singapore's Dr Buddy. It signifies that YIDU TECH's hospital intelligent solutions, centered around its AI middleware platform, have successfully integrated into the hospital's business processes and operational system-level construction.
The project aims to build an integrated artificial intelligence management system for ZSCC, establishing a unified intelligent algorithm and model library. Based on open-source large models and specialized medical vertical models, it will support the research and development of small models for specific tasks through SFT training. Simultaneously, AI capabilities will be opened to business applications in the form of intelligent agent APIs, breaking down data and technical barriers, promoting collaborative innovation among various internal business systems, achieving unified management of AI R&D and application, and comprehensively enhancing the application efficiency of AI technology in fields such as medical care, scientific research, management, and patient services.
This collaboration is not the first between the two parties. Since 2015, ZSCC and YIDU TECH have engaged in deep cooperation around a specialized oncology big data platform. Leveraging its core algorithm engine YiduCore, YIDU TECH assisted ZSCC in building China's first oncology big data platform with T+0 real-time updates. It integrated data from over 30 core business systems, creating a "living map" of medical data covering the entire disease course of more than 2 million patients. In February 2026, YIDU TECH again assisted ZSCC in achieving the private deployment of an AI middleware platform, using YiduCore and DeepSeek as dual engines, and was among the first to empower clinical scenarios with an intelligent diagnosis and treatment assistant.
Recently, Boyu Investment, Citigroup, GF Securities, and several leading private equity institutions conducted special research at ZSCC, conducting on-site inspections of the deeply implemented results of the collaboration. Following the research, Citigroup issued a report maintaining a "Buy" rating with a target price of HKD 11. It explicitly stated that hospital AI-related budgets are expected to continue rising and that YIDU TECH's professional clinical data governance capabilities constitute a core competitive barrier.
In terms of recent developments, on April 20, YIDU TECH issued a positive profit forecast, expecting a net profit of RMB 55 million to 70 million for the 2026 fiscal year (ending March 31, 2026). This represents the company's first full-year turnaround to profitability since its establishment 11 years ago, with the inflection point in profitability and the momentum of performance growth beginning to show. Subsequently, the company announced consecutive wins of projects including the Beijing Cancer Hospital AI Large Model Project, the Hainan Provincial Coordinated Regional Infectious Disease Surveillance and Early Warning Platform (Phase II) (approximately RMB 12.89 million), the Hainan Smart Health Island Construction Project (approximately RMB 14.76 million), and the project for Singapore's largest public healthcare group, Dr Buddy (approximately RMB 12.20 million).
YIDU TECH is accelerating the validation of its AI commercialization closed loop, with the continuous repurchase by benchmark customers forming its fundamental base. Market analysis points out that from the early co-construction of big data platforms, to the private deployment of AI middleware platforms, and now to the nearly RMB 10 million smart clinical and settlement project, YIDU TECH is elevating its collaboration with China's top oncology hospital to the operational system level. As deep AI construction expands in top hospitals like ZSCC, YIDU TECH is expected to be among the first to enter a cycle of simultaneous growth in both performance and valuation.
Comments